These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22587419)

  • 1. A key structural domain of the Candida albicans Mdr1 protein.
    Mandal A; Kumar A; Singh A; Lynn AM; Kapoor K; Prasad R
    Biochem J; 2012 Aug; 445(3):313-22. PubMed ID: 22587419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
    Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ
    Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
    J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the P-glycoprotein first intracellular loop and flanking transmembrane domains.
    Kwan T; Gros P
    Biochemistry; 1998 Mar; 37(10):3337-50. PubMed ID: 9521654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
    Looi CY; D' Silva EC; Seow HF; Rosli R; Ng KP; Chong PP
    FEMS Microbiol Lett; 2005 Aug; 249(2):283-9. PubMed ID: 16006060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug susceptibilities of yeast cells are affected when expressing mutant Candida albicans drug resistance protein.
    Gao PH; Cao YB; Jia XM; Cao YY; Quan H; Wang Y; Jiang YY
    Int J Antimicrob Agents; 2006 Jul; 28(1):69-74. PubMed ID: 16782311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABC transporter Cdr1p harbors charged residues in the intracellular loop and nucleotide-binding domain critical for protein trafficking and drug resistance.
    Shah AH; Banerjee A; Rawal MK; Saxena AK; Mondal AK; Prasad R
    FEMS Yeast Res; 2015 Aug; 15(5):fov036. PubMed ID: 26048893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
    Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
    Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter.
    Karnani N; Gaur NA; Jha S; Puri N; Krishnamurthy S; Goswami SK; Mukhopadhyay G; Prasad R
    Yeast; 2004 Feb; 21(3):219-39. PubMed ID: 14968428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atomic modelling and systematic mutagenesis identify residues in multiple drug binding sites that are essential for drug resistance in the major Candida transporter Cdr1.
    Nim S; Lobato LG; Moreno A; Chaptal V; Rawal MK; Falson P; Prasad R
    Biochim Biophys Acta; 2016 Nov; 1858(11):2858-2870. PubMed ID: 27569110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Basis of Substrate Polyspecificity of the Candida albicans Mdr1p Multidrug/H
    Redhu AK; Banerjee A; Shah AH; Moreno A; Rawal MK; Nair R; Falson P; Prasad R
    J Mol Biol; 2018 Mar; 430(5):682-694. PubMed ID: 29341887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of key residues in the C-methyltransferase domain of a fungal highly reducing polyketide synthase.
    Skellam EJ; Hurley D; Davison J; Lazarus CM; Simpson TJ; Cox RJ
    Mol Biosyst; 2010 Apr; 6(4):680-2. PubMed ID: 20237645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABC multidrug transporter Cdr1p of Candida albicans has divergent nucleotide-binding domains which display functional asymmetry.
    Jha S; Dabas N; Karnani N; Saini P; Prasad R
    FEMS Yeast Res; 2004 Oct; 5(1):63-72. PubMed ID: 15381123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a functional Candida albicans homolog of the Saccharomyces cerevisiae TCO89 gene.
    Zheng C; Yan Z; Liu W; Jiang L
    FEMS Yeast Res; 2007 Jun; 7(4):558-68. PubMed ID: 17298473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ALS5 gene of Candida albicans and analysis of the Als5p N-terminal domain.
    Hoyer LL; Hecht JE
    Yeast; 2001 Jan; 18(1):49-60. PubMed ID: 11124701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDR1-mediated drug resistance in Candida dubliniensis.
    Wirsching S; Moran GP; Sullivan DJ; Coleman DC; Morschhäuser J
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3416-21. PubMed ID: 11709317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic isoforms of the H+/nucleoside co-transporter (CaCNT) from Candida albicans reveal separate high- and low-affinity transport systems for nucleosides.
    Slugoski MD; Loewen SK; Ng AM; Baldwin SA; Cass CE; Young JD
    Yeast; 2004 Nov; 21(15):1269-77. PubMed ID: 15543539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ABCs of Candida albicans Multidrug Transporter Cdr1.
    Prasad R; Banerjee A; Khandelwal NK; Dhamgaye S
    Eukaryot Cell; 2015 Dec; 14(12):1154-64. PubMed ID: 26407965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic variants of ABC drug transporter Cdr1p in clinical isolates of Candida albicans.
    Haque A; Rai V; Bahal BS; Shukla S; Lattif AA; Mukhopadhyay G; Prasad R
    Biochem Biophys Res Commun; 2007 Jan; 352(2):491-7. PubMed ID: 17126815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional characterization of the mouse multidrug resistance gene family.
    Dhir R; Buschman E; Gros P
    Bull Cancer; 1990; 77(11):1125-9. PubMed ID: 1980424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.